These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15274674)

  • 1. Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design.
    Madsen LG; Bytzer P
    Aliment Pharmacol Ther; 2004 Aug; 20(3):365-72. PubMed ID: 15274674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?
    Madsen LG; Wallin L; Bytzer P
    Aliment Pharmacol Ther; 2004 Aug; 20(4):423-30. PubMed ID: 15298636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model.
    Madsen LG; Bytzer P
    Dig Dis; 2008; 26(3):237-42. PubMed ID: 18463442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying responders to acid suppression in dyspepsia using a random starting day trial.
    Bytzer P; Hansen JM; Rune S; Bonnevie O; Breinstrup H; Funch-Jensen P; Matzen P; Meineche-Schmidt V; Schaffalitzky De Muckadell OB
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1485-94. PubMed ID: 11069320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which dyspepsia patients will benefit from omeprazole treatment? Analysis of a Danish multicenter trial.
    Meineche-Schmidt V; Christensen E
    Am J Gastroenterol; 2000 Oct; 95(10):2777-83. PubMed ID: 11051347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia.
    Gerson LB; Triadafilopoulos G
    Dig Liver Dis; 2005 Feb; 37(2):87-91. PubMed ID: 15733519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of the placebo response in functional dyspepsia.
    Talley NJ; Locke GR; Lahr BD; Zinsmeister AR; Cohard-Radice M; D'Elia TV; Tack J; Earnest DL
    Aliment Pharmacol Ther; 2006 Apr; 23(7):923-36. PubMed ID: 16573795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of dyspepsia and response to treatment with proton-pump inhibitors.
    Meineche-Schmidt V
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1171-9. PubMed ID: 15569120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
    Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
    Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome.
    Lewin van den Broek NT; Numans ME; Buskens E; Verheij TJ; de Wit NJ; Smout AJ
    Br J Gen Pract; 2001 Aug; 51(469):619-24. PubMed ID: 11510389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia.
    Kato M; Watanabe M; Konishi S; Kudo M; Konno J; Meguro T; Kitamori S; Nakagawa S; Shimizu Y; Takeda H; Asaka M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():27-31. PubMed ID: 15943843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials.
    Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun AN; Thomson AB; Mann V; Escobedo S; Chakraborty B; Nevin K
    Aliment Pharmacol Ther; 2006 Feb; 23(4):521-9. PubMed ID: 16441473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
    Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
    Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
    Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the symptomatology and quality of life in functional dyspepsia before and after Helicobacter pylori eradication treatment].
    Ladrón de Guevara L; Peña-Alfaro NG; Padilla L; Lichtinger A; Figueroa S; Shapiro I; Rubinstein M; Di Silvio M
    Rev Gastroenterol Mex; 2004; 69(4):203-8. PubMed ID: 15765971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
    van Kerkhoven LA; Laheij RJ; Aparicio N; De Boer WA; Van den Hazel S; Tan AC; Witteman BJ; Jansen JB
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):746-52; quiz 718. PubMed ID: 18424191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study.
    Kupcinskas L; Lafolie P; Lignell A; Kiudelis G; Jonaitis L; Adamonis K; Andersen LP; Wadström T
    Phytomedicine; 2008 Jun; 15(6-7):391-9. PubMed ID: 18467083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
    Tan HJ; Rizal AM; Rosmadi MY; Goh KL
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):110-5. PubMed ID: 16706821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.